The 22 most recent market catalysts affecting $XYL, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 13, 2026
Corporate Catalyst
Bullish
Impact 75
Xylem Inc. Approves $1.5 Billion Share Repurchase Program
Xylem Inc.'s Board of Directors has authorized a new share repurchase program of up to $1.5 billion. This is a significant capital allocation decision, indicating that management b…
Oct 28, 2026
Corporate Catalyst
Neutral
Impact 65
Multiple Analysts Adjust Ratings and Price Targets for Xylem Inc.
On October 28, 2026, several prominent financial institutions adjusted their outlooks for Xylem Inc. JPMorgan notably downgraded the stock from Neutral to Underweight, setting a $9…
Oct 27, 2026
Corporate Catalyst
Bearish
Impact 92
Xylem Reports Q3 2026 Financial Results and Updates 2026 Outlook
Xylem's Q3 2026 earnings report revealed a miss on both top and bottom lines, falling short of FactSet consensus estimates. More significantly, the company revised its full-year 20…
Oct 19, 2026
Corporate Catalyst
Bearish
Impact 55
JP Morgan Maintains Neutral on Xylem, Lowers Price Target to $118
JP Morgan's decision to lower Xylem's price target from $137 to $118, while maintaining a Neutral rating, indicates a more cautious stance on the company's valuation. This move sug…
Oct 14, 2026
Corporate Catalyst
Bearish
Impact 55
Oppenheimer Reiterates Outperform on Xylem, Lowers Price Target to $150
Oppenheimer analyst Bryan Blair reiterated an 'Outperform' rating for Xylem, signaling continued confidence in the company's long-term prospects. However, the price target was lowe…
Oct 14, 2026
Corporate Catalyst
Bearish
Impact 65
RBC Capital Maintains Outperform on Xylem, Lowers Price Target to $135
RBC Capital's decision to lower Xylem's price target from $164 to $135, while maintaining an 'Outperform' rating, indicates a recalibration of valuation expectations. This could be…
Oct 13, 2026
Corporate Catalyst
Bearish
Impact 55
Barclays Maintains Overweight on Xylem, Lowers Price Target to $139
Barclays analyst William Grippin maintained an 'Overweight' rating on Xylem, signaling continued confidence in the company's long-term prospects. However, the price target was lowe…
Oct 12, 2026
Corporate Catalyst
Bearish
Impact 55
Citigroup Maintains Buy on Xylem, Lowers Price Target to $148
Citigroup analyst Andrew Kaplowitz lowered the price target for Xylem (XYL) from $172 to $148, while simultaneously reiterating a 'Buy' rating. This action suggests that while the …
Oct 5, 2026
Corporate Catalyst
Bearish
Impact 55
UBS Maintains Neutral on Xylem, Lowers Price Target to $112
This 8-K filing discloses that UBS analyst Joshua Spector has maintained a 'Neutral' rating on Xylem (XYL) but has reduced the price target from $138 to $112. This matters because …
Aug 18, 2026
Corporate Catalyst
Bearish
Impact 85
Xylem shares are trading lower after the company announced an executive transition and affirmed its Q3 and FY26 sales guidance below analyst estimates.
The combination of an executive transition and affirmed sales guidance below analyst estimates is a significant negative catalyst for Xylem. Executive changes often introduce uncer…
Aug 18, 2026
Corporate Catalyst
Neutral
Impact 65
Xylem Appoints Andrea van der Berg As Executive VP And CFO Effective September 1, Succeeding William “Bill” Grogan
Xylem Inc. has announced a change in its Chief Financial Officer position. Andrea van der Berg will take over from William 'Bill' Grogan, effective September 1, 2026. This is a not…
Jul 30, 2026
Corporate Catalyst
Bullish
Impact 55
UBS Maintains Neutral on Xylem, Raises Price Target to $135
UBS analyst Joshua Spector updated their coverage on Xylem, raising the price target from $129 to $135 while maintaining a 'Neutral' rating. This adjustment reflects a slightly imp…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 55
RBC Capital Maintains Outperform on Xylem, Raises Price Target to $164
RBC Capital analyst Deane Dray maintained an 'Outperform' rating on Xylem and raised the price target from $159 to $164. This indicates a positive outlook from a prominent financia…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 55
Barclays Maintains Overweight on Xylem, Raises Price Target to $159
Barclays analyst William Grippin maintained an 'Overweight' rating on Xylem and raised the price target from $154 to $159. This action signals a continued bullish sentiment from a …
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 55
Baird Maintains Outperform on Xylem, Raises Price Target to $165
Baird analyst Michael Halloran maintained an 'Outperform' rating on Xylem and raised the price target from $163 to $165. This action signals a continued positive view on the compan…
Jul 28, 2026
Corporate Catalyst
Bullish
Impact 85
Xylem shares are trading higher after the company reported better-than-expected Q2 earnings results and raised its FY26 guidance.
This headline is a significant positive catalyst for Xylem (XYL) due to the dual impact of beating Q2 earnings expectations and, more importantly, raising its long-term FY26 guidan…
Jul 16, 2026
Corporate Catalyst
Bullish
Impact 55
RBC Capital Maintains Outperform on Xylem, Raises Price Target to $159
RBC Capital analyst Deane Dray has reaffirmed an 'Outperform' rating on Xylem (XYL) and modestly raised the price target from $157 to $159. This action signals continued analyst co…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.